Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Tabak ShawnCHIEF FINANCIAL OFFICER | Open-market sale | SELL | $21K 2,969 sh | Apr 9, 2026 |
| 22 | Mills MattPresident | Open-market sale · 10b5-1 plan | SELL | $317K 24.7K sh | Apr 9, 2026 traded Apr 8, 2026 |
| 21 | Kim Sarah EEVP, CLO & Corporate Secretary | Option exercise | M | — 55.6K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | MacIntyre VitaController | Grant or award | A | — 909 sh | Apr 9, 2026 traded Apr 8, 2026 |
| 21 | Kim Sarah EEVP, CLO & Corporate Secretary | Option exercise | M | — 55.6K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Chitale AparnaCPO & EVP Astronaut Operations | Option exercise | M | — 66.0K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Colglazier Michael ADirector, CEO and President | Option exercise | M | — 275.7K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Bauer JakeDirector | Grant or award | A | — 13.9K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Venker EricDirector, Chief Executive Officer | Grant or award | A | — 232.3K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Susman Robert GrahamDirector | Grant or award | A | — 13.9K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Chitale AparnaCPO & EVP Astronaut Operations | Option exercise | M | — 66.0K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Greenwood Matthew AChief Commercial Officer | Grant or award | A | — 150.0K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Scrogham StevenCLO, CCO & Corp. Sec. | Grant or award | A | — 150.0K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Harbour AustinChief Financial Officer | Grant or award | A | — 270.0K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Bassano KeithCFO AND TREASURER | Grant or award | A | — 20.7K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Wei XiaoyangChief Financial Officer | Grant or award | A | — 12.0K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Wilson MeridethFinancial Health GM | Grant or award | A | — 5,206 sh | Apr 9, 2026 traded Apr 8, 2026 |
| 21 | Schwartz LarissaSee Remarks | Open-market sale · 10b5-1 plan | SELL | $342K 4,278 sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Colglazier Michael ADirector, CEO and President | Option exercise | M | — 275.7K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 21 | Swain Clinton M.Director | NONEWILSON BANK HOLDING CO Option exercise | M | — 2,000 sh | Apr 9, 2026 traded Apr 9, 2026 |
| 20 | Caljouw Lynne JEVP, Chief HR Officer | Open-market sale | SELL | $101K 2,913 sh | Apr 9, 2026 traded Apr 7, 2026 |
| 20 | Devine Darren PaulDirector | Option exercise | M | $129K 10.3K sh | Apr 9, 2026 traded Apr 8, 2026 |
| 19 | Girardin SteveDirector | Grant or award | A | — 1 sh | Apr 9, 2026 traded Apr 1, 2026 |
| 19 | Payne AbbyChief People Officer | Open-market sale · 10b5-1 plan | SELL | $184K 16.1K sh | Apr 9, 2026 traded Apr 9, 2026 |
| 19 | Santos Sandra Maria SoaresDirector | Option exercise | M | — 5,849 sh | Apr 9, 2026 traded Mar 31, 2026 |
| 19 | Bachmann James W.Director | Option exercise | M | — 5,849 sh | Apr 9, 2026 traded Mar 31, 2026 |
| 19 | Gnanasambandam ChandrasekarEVP Product & CTO | Open-market sale · 10b5-1 plan | SELL | $108K 8,467 sh | Apr 9, 2026 traded Apr 8, 2026 |
| 19 | Shah Nirav VimalGroup Head Corporate Banking | In-the-money exercise | X | $544K 80.0K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 19 | Gnanasambandam ChandrasekarEVP Product & CTO | Open-market sale · 10b5-1 plan | SELL | $219K 19.1K sh | Apr 9, 2026 traded Apr 9, 2026 |
| 19 | Payne AbbyChief People Officer | Open-market sale · 10b5-1 plan | SELL | $157K 12.3K sh | Apr 9, 2026 traded Apr 8, 2026 |
| 19 | Van der Smissen Willem Jozef LudwigDirector | Option exercise | M | — 5,849 sh | Apr 9, 2026 traded Mar 31, 2026 |
| 19 | Dubin RyanDirector | Grant or award | A | — 68.8K sh | Apr 9, 2026 traded Mar 30, 2026 |
| 19 | Bachmann James W.Director | Option exercise | M | — 5,849 sh | Apr 9, 2026 traded Mar 31, 2026 |
| 19 | Shlomi Ben HaimDirector, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $996K 20.4K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 19 | McClain Mark D.Director, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $53K 4,342 sh | Apr 9, 2026 traded Apr 9, 2026 |
| 19 | Payne AbbyChief People Officer | Open-market sale · 10b5-1 plan | SELL | $156K 12.3K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 19 | Santos Sandra Maria SoaresDirector | Option exercise | M | — 5,849 sh | Apr 9, 2026 traded Mar 31, 2026 |
| 19 | Schmitt ChristopherGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $173K 13.6K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 19 | Girardin SteveDirector | Grant or award | A | — 2.70M sh | Apr 9, 2026 traded Apr 1, 2026 |
| 19 | Schmitt ChristopherGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $174K 13.6K sh | Apr 9, 2026 traded Apr 8, 2026 |